2016 / 01

Next Paper
DOI: 10.24075/brsmu.2016-01-02

ORIGINAL RESEARCH

Neurodegenerative changes induced by injection of β-amyloid peptide fragment (25-35) in hippocampus are associated with NGF-signalling activation

Stepanichev MYu, Ivanov AD, Lazareva NA, Moiseeva YuV, Gulyaeva NV
About authors

Functional Biochemistry of Nervous System Laboratory,
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia

Correspondence should be addressed: Mikhail Stepanichev
ul. Butlerova, d. 5А, Moscow, Russia, 117485; moc.oohay@vehcinapets_liahkim

About paper

Funding: this study was supported by the Russian Foundation for Basic Research (grants no. 13-04-01019a and 16-04-01054a ).

Received: 2016-02-14 Accepted: 2016-02-19 Published online: 2017-01-05
|
  1. Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25–35). Exp Neurol. 2010 Jan; 221 (1): 26–37.
  2. Gulyaeva NV, Stepanichev MYu. Abeta(25–35) as proxyholder for amyloidogenic peptides: in vivo evidence. Exp Neurol. 2010 Mar; 222 (1): 6–9.
  3. Rush DK, Aschmies S, Merriman MC. Intracerebral β-amyloid(25–35) produces tissue damage: is it neurotoxic? Neurobiol Aging. 1992 Sep–Oct; 13 (5): 591–4.
  4. Sigurdsson EM, Hejna MJ, Lee JM, Lorens SA. beta-Amyloid 25–35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: behavioral, neurochemical and histological effects. Behav Brain Res. 1995 Dec 14; 72 (1–2): 141–56.
  5. Stepanichev MYu, Onufriev MV, Moiseeva YuV, Yakovlev AA, Lazareva NA, Gulyaeva NV. Vliyanie faktora nekroza opukholi-al'fa i beta-amiloidnogo peptida (25–35) na pokazateli svobodnoradikal’nogo okisleniya i aktivnost' kaspazy-3 v mozge krys. Neirokhimiya. 2006; 23 (3): 217–22. Russian.
  6. Arias C, Montiel T, Quiroz-Báez R, Massieu L. β-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease. Exp Neurol. 2002 Jul; 176 (1): 163–74.
  7. Montiel T, Quiroz-Baez R, Massieu L, Arias C. Role of oxidative stress on β-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants. Exp Neurol. 2006 Aug; 200 (2): 496–508.
  8. Stepanichev MYu, Zdobnova IM, Yakovlev AA, Onufriev MV, Lazareva NA, Zarubenko II, et al. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25–35). J Neurosci Res. 2003 Jan 1; 71 (1): 110–20.
  9. Manukhina EB, Pshennikova MG, Goryacheva AV, Khomenko IP, Mashina SI, Pokidyshev DA, et al. Role of nitric oxide in prevention of cognitive disorders in neurodegenerative brain injuries in rats. Bull Exp Biol Med. 2008 Oct; 146 (4): 391–5.
  10. Sigurdsson EM, Lorens SA, Hejna MJ, Dong XW, Lee JM. Local and distant histopathological effects of unilateral amyloid-beta 25–35 injections into the amygdala of young F344 rats. Neurobiol Aging. 1996 Nov–Dec; 17 (6): 893–901.
  11. Steardo L Jr, Bronzuoli MR, Iacomino A, Esposito G, Steardo L, Scuderi C. Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes. Front Neurosci. 2015 Jul 29; 9: 259.
  12. Niewiadomska G, Mietelska-Porowska A, Mazurkiewicz M. The cholinergic system, nerve growth factor and the cytoskeleton. Behav Brain Res. 2011 Aug 10; 221 (2): 515–26.
  13. Mesulam M. Cholinergic aspects of aging and Alzheimer's disease. Biol Psychiatry. 2012 May 1; 71 (9): 760–1.
  14. Zhou Y, Lu TJ, Xiong ZQ. NGF-dependent retrograde signaling: survival versus death. Cell Res. 2009 May; 19 (5): 525–6.
  15. Schaub RT, Anders D, Golz G, Göhringer K, Hellweg R. Serum nerve growth factor concentration and its role in the preclinical stage of dementia. Am J Psychiatry. 2002 Jul; 159 (7): 1227–9.
  16. Counts SE, He B, Prout JG, Michalski B, Farotti L, Fahnestock M, et al. Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer's disease. Curr Alzheimer Res. Epub 2016 Jan 28. PubMed PMID: 26825093.
  17. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; 1982.
  18. Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res. 1996 Jan 15; 706 (2): 181–93.
  19. Stepanichev MYu, Flegontova OV, Lazareva NA, Egorova LK, Gulyaeva NV. Vliyanie protivovospalitel'nogo tsitokina interleikina-4 na neirodegeneratsiyu u krys, vyzvannuyu beta-amiloidnym peptidom. Neirokhimiya. 2006; 23(1): 67–72. Russian.
  20. Miguel-Hidalgo JJ, Cacabelos R. Beta-amyloid(1–40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathol. 1998 May; 95 (5): 455–65.
  21. Meeker RB, Williams KS. The p75 neurotrophin receptor: at the crossroad of neural repair and death. Neural Regen Res. 2015 May; 10 (5): 721–5.
  22. Armato U, Chakravarthy B, Pacchiana R, Whitfield JF. Alzheimer's disease: an update of the roles of receptors, astrocytes and primary cilia (review). Int J Mol Med. 2013 Jan; 31 (1): 3–10.
  23. Chakravarthy B, Gaudet C, Ménard M, Atkinson T, Brown L, Laferla FM, et al. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis. 2010; 19 (3): 915–25.
  24. Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci. 2005 Aug; 8 (8): 1069–77.
  25. Bernabeu RO, Longo FM. The p75 neurotrophin receptor is expressed by adult mouse dentate progenitor cells and regulates neuronal and non-neuronal cell genesis. BMC Neurosci. 2010 Oct 20; 11: 136.
  26. Yu W, Zhu H, Wang Y, Li G, Wang L, Li H. Reactive transformation and increased BDNF signaling by hippocampal astrocytes in response to MK-801. PLoS One. 2015 Dec 23; 10 (12): e0145651.
  27. Wong I, Liao H, Bai X, Zaknic A, Zhong J, Guan Y, et al. ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury. Brain Behav Immun. 2010 May; 24 (4): 585–97.
  28. Niewiadomska G, Komorowski S, Baksalerska-Pazera M. Amelioration of cholinergic neurons dysfunction in aged rats depends on the continuous supply of NGF. Neurobiol Aging. 2002 Jul–Aug; 23 (4): 601–13.
  29. Ichim G, Tauszig-Delamasure S, Mehlen P. Neurotrophins and cell death. Exp Cell Res. 2012 Jul 1; 318 (11): 1221–8.
  30. Iulita MF, Cuello AC. Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome. Trends Pharmacol Sci. 2014 Jul; 35 (7): 338–48.